Revlimid News
Most Popular Revlimid Story
Celgene to look beyond Revlimid at R&D day
During Celgene's R&D day tomorrow--the first it has hosted in five years--the developer will attempt to show analysts that it has a promising drug pipeline beyond Revlimid, its top-selling Read more...
Latest Headlines
- April 7, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
